231 results
8-K
EX-99.1
IMNN
Imunon Inc
8 May 24
IMUNON Appoints Director Dr. Stacy R. Lindborg as President and CEO
8:15am
for the study and reporting of data, the potential efficacy and safety profile of our PlaCCine platform, potential partnering opportunities
8-K
EX-99.1
IMNN
Imunon Inc
28 Mar 24
IMUNON Reports 2023 Financial Results and Provides Business Update
8:05am
application. Our objective is to confirm the safety and immunogenicity of our clinical vaccine in humans. Based on these results, we will advance … is evaluating the dosing, safety, efficacy and biological activity of intraperitoneal IMNN-001 in combination with NACT in patients newly diagnosed
8-K
EX-99.1
ggagl
14 Nov 23
IMUNON Reports Third Quarter 2023 Financial Results and Provides a Business Update
12:00am
8-K
EX-99.1
8kaev56pm5lm4ljjd
10 Aug 23
IMUNON Reports Second Quarter 2023 Financial Results and Provides Business Update
8:09am
8-K
EX-99.1
q4gueou
11 May 23
IMUNON Reports First Quarter 2023 Financial Results and Provides Business Update
8:05am
8-K
EX-99.1
uzn42
30 Mar 23
IMUNON Reports 2022 Financial Results and Provides Business Update
8:05am
8-K
EX-99.1
jpl94glsk1s vgfyiiwo
15 Nov 22
Third Quarter 2022 Conference Call
9:07am
8-K
EX-99.1
bmluvb
14 Nov 22
IMUNON Reports Third Quarter 2022 Financial Results
8:11am